Press Releases
Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility
Thermo Fisher Scientific, the world leader in serving science, unveiled the $6 million expansion of its gene therapy and viral vector services site in...
Press Releases
Novartis opens new cell and gene therapies facility in Switzerland
Swiss pharmaceutical company Novartis has opened a new manufacturing facility for cell and gene therapies at Stein in Switzerland.
The new facility also facilitates the...
Press Releases
Recipharm announces commercial manufacturing to support Talicia® Q1/2020 launch following U.S. FDA approval
Recipharm, the contract development and manufacturing organisation , announced ongoing large-scale commercial manufacturing of RedHill Biopharma’s drug, Talicia delayed-release capsules 10 mg /250 mg/12.5...
Drug Research
Aptar Pharma, Platinum Sponsor at DDL 2019, to Showcase Expanded Portfolio of Respiratory Innovations and Services
Aptar Pharma, a leading drug delivery systems provider, announces its Platinum Sponsorship of this year’s Drug Delivery to the Lung (DDL) Conference 2019, which...
Clinical Trials
Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials
The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs and special...
Clinical Trials
ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer
ERYTECH Pharma a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that the full results from...
Drug Research
Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine Tumors
Hutchison China MediTech Limited announces that the U.S. FDA has granted Orphan Drug designation to surufatinib for the treatment of pancreatic neuroendocrine tumors.
“NET is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read